Global Influenza Vaccination Market Research Report 2023

Report ID: 1983488 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Egg Based
        1.2.3 Cell Culture
        1.2.4 Recombinant
    1.3 Market by Application
        1.3.1 Global Influenza Vaccination Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Research Organizations
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Influenza Vaccination Market Perspective (2017-2028)
    2.2 Influenza Vaccination Growth Trends by Region
        2.2.1 Influenza Vaccination Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Influenza Vaccination Historic Market Size by Region (2017-2022)
        2.2.3 Influenza Vaccination Forecasted Market Size by Region (2023-2028)
    2.3 Influenza Vaccination Market Dynamics
        2.3.1 Influenza Vaccination Industry Trends
        2.3.2 Influenza Vaccination Market Drivers
        2.3.3 Influenza Vaccination Market Challenges
        2.3.4 Influenza Vaccination Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Influenza Vaccination Players by Revenue
        3.1.1 Global Top Influenza Vaccination Players by Revenue (2017-2022)
        3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2017-2022)
    3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Influenza Vaccination Revenue
    3.4 Global Influenza Vaccination Market Concentration Ratio
        3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2021
    3.5 Influenza Vaccination Key Players Head office and Area Served
    3.6 Key Players Influenza Vaccination Product Solution and Service
    3.7 Date of Enter into Influenza Vaccination Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Vaccination Breakdown Data by Type
    4.1 Global Influenza Vaccination Historic Market Size by Type (2017-2022)
    4.2 Global Influenza Vaccination Forecasted Market Size by Type (2023-2028)
5 Influenza Vaccination Breakdown Data by Application
    5.1 Global Influenza Vaccination Historic Market Size by Application (2017-2022)
    5.2 Global Influenza Vaccination Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Influenza Vaccination Market Size (2017-2028)
    6.2 North America Influenza Vaccination Market Size by Country (2017-2022)
    6.3 North America Influenza Vaccination Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Influenza Vaccination Market Size (2017-2028)
    7.2 Europe Influenza Vaccination Market Size by Country (2017-2022)
    7.3 Europe Influenza Vaccination Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Influenza Vaccination Market Size (2017-2028)
    8.2 Asia-Pacific Influenza Vaccination Market Size by Country (2017-2022)
    8.3 Asia-Pacific Influenza Vaccination Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Influenza Vaccination Market Size (2017-2028)
    9.2 Latin America Influenza Vaccination Market Size by Country (2017-2022)
    9.3 Latin America Influenza Vaccination Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Influenza Vaccination Market Size (2017-2028)
    10.2 Middle East & Africa Influenza Vaccination Market Size by Country (2017-2022)
    10.3 Middle East & Africa Influenza Vaccination Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott (U.S.)
        11.1.1 Abbott (U.S.) Company Detail
        11.1.2 Abbott (U.S.) Business Overview
        11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
        11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2017-2022)
        11.1.5 Abbott (U.S.) Recent Development
    11.2 AstraZeneca (Europe)
        11.2.1 AstraZeneca (Europe) Company Detail
        11.2.2 AstraZeneca (Europe) Business Overview
        11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
        11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.2.5 AstraZeneca (Europe) Recent Development
    11.3 BioCryst Pharmaceuticals (U.S.)
        11.3.1 BioCryst Pharmaceuticals (U.S.) Company Detail
        11.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
        11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Introduction
        11.3.4 BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2017-2022)
        11.3.5 BioCryst Pharmaceuticals (U.S.) Recent Development
    11.4 Novartis (Europe)
        11.4.1 Novartis (Europe) Company Detail
        11.4.2 Novartis (Europe) Business Overview
        11.4.3 Novartis (Europe) Influenza Vaccination Introduction
        11.4.4 Novartis (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.4.5 Novartis (Europe) Recent Development
    11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
        11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
        11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
        11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Introduction
        11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022)
        11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
    11.6 GlaxoSmithKline (Europe)
        11.6.1 GlaxoSmithKline (Europe) Company Detail
        11.6.2 GlaxoSmithKline (Europe) Business Overview
        11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Introduction
        11.6.4 GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.6.5 GlaxoSmithKline (Europe) Recent Development
    11.7 Hualan Biological Engineering (Asia Pacific)
        11.7.1 Hualan Biological Engineering (Asia Pacific) Company Detail
        11.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
        11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Introduction
        11.7.4 Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022)
        11.7.5 Hualan Biological Engineering (Asia Pacific) Recent Development
    11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
        11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
        11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
        11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Introduction
        11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022)
        11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
    11.9 F. Hoffmann-La Roche (Europe)
        11.9.1 F. Hoffmann-La Roche (Europe) Company Detail
        11.9.2 F. Hoffmann-La Roche (Europe) Business Overview
        11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Introduction
        11.9.4 F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.9.5 F. Hoffmann-La Roche (Europe) Recent Development
    11.10 Sanofi (Europe)
        11.10.1 Sanofi (Europe) Company Detail
        11.10.2 Sanofi (Europe) Business Overview
        11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
        11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.10.5 Sanofi (Europe) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Egg Based
    Table 3. Key Players of Cell Culture
    Table 4. Key Players of Recombinant
    Table 5. Global Influenza Vaccination Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Influenza Vaccination Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Influenza Vaccination Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Influenza Vaccination Market Share by Region (2017-2022)
    Table 9. Global Influenza Vaccination Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Influenza Vaccination Market Share by Region (2023-2028)
    Table 11. Influenza Vaccination Market Trends
    Table 12. Influenza Vaccination Market Drivers
    Table 13. Influenza Vaccination Market Challenges
    Table 14. Influenza Vaccination Market Restraints
    Table 15. Global Influenza Vaccination Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Influenza Vaccination Market Share by Players (2017-2022)
    Table 17. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2021)
    Table 18. Ranking of Global Top Influenza Vaccination Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Influenza Vaccination Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Influenza Vaccination Product Solution and Service
    Table 22. Date of Enter into Influenza Vaccination Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Influenza Vaccination Revenue Market Share by Type (2017-2022)
    Table 26. Global Influenza Vaccination Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Influenza Vaccination Revenue Market Share by Type (2023-2028)
    Table 28. Global Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Influenza Vaccination Revenue Market Share by Application (2017-2022)
    Table 30. Global Influenza Vaccination Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Influenza Vaccination Revenue Market Share by Application (2023-2028)
    Table 32. North America Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Influenza Vaccination Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Influenza Vaccination Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbott (U.S.) Company Detail
    Table 43. Abbott (U.S.) Business Overview
    Table 44. Abbott (U.S.) Influenza Vaccination Product
    Table 45. Abbott (U.S.) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 46. Abbott (U.S.) Recent Development
    Table 47. AstraZeneca (Europe) Company Detail
    Table 48. AstraZeneca (Europe) Business Overview
    Table 49. AstraZeneca (Europe) Influenza Vaccination Product
    Table 50. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 51. AstraZeneca (Europe) Recent Development
    Table 52. BioCryst Pharmaceuticals (U.S.) Company Detail
    Table 53. BioCryst Pharmaceuticals (U.S.) Business Overview
    Table 54. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product
    Table 55. BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 56. BioCryst Pharmaceuticals (U.S.) Recent Development
    Table 57. Novartis (Europe) Company Detail
    Table 58. Novartis (Europe) Business Overview
    Table 59. Novartis (Europe) Influenza Vaccination Product
    Table 60. Novartis (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 61. Novartis (Europe) Recent Development
    Table 62. DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
    Table 63. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
    Table 64. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product
    Table 65. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 66. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
    Table 67. GlaxoSmithKline (Europe) Company Detail
    Table 68. GlaxoSmithKline (Europe) Business Overview
    Table 69. GlaxoSmithKline (Europe) Influenza Vaccination Product
    Table 70. GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 71. GlaxoSmithKline (Europe) Recent Development
    Table 72. Hualan Biological Engineering (Asia Pacific) Company Detail
    Table 73. Hualan Biological Engineering (Asia Pacific) Business Overview
    Table 74. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product
    Table 75. Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 76. Hualan Biological Engineering (Asia Pacific) Recent Development
    Table 77. Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
    Table 78. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
    Table 79. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product
    Table 80. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 81. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
    Table 82. F. Hoffmann-La Roche (Europe) Company Detail
    Table 83. F. Hoffmann-La Roche (Europe) Business Overview
    Table 84. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product
    Table 85. F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 86. F. Hoffmann-La Roche (Europe) Recent Development
    Table 87. Sanofi (Europe) Company Detail
    Table 88. Sanofi (Europe) Business Overview
    Table 89. Sanofi (Europe) Influenza Vaccination Product
    Table 90. Sanofi (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 91. Sanofi (Europe) Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Vaccination Market Share by Type: 2021 VS 2028
    Figure 2. Egg Based Features
    Figure 3. Cell Culture Features
    Figure 4. Recombinant Features
    Figure 5. Global Influenza Vaccination Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Research Organizations Case Studies
    Figure 8. Influenza Vaccination Report Years Considered
    Figure 9. Global Influenza Vaccination Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Influenza Vaccination Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Influenza Vaccination Market Share by Region: 2021 VS 2028
    Figure 12. Global Influenza Vaccination Market Share by Players in 2021
    Figure 13. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2021
    Figure 15. North America Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Influenza Vaccination Market Share by Country (2017-2028)
    Figure 17. United States Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Influenza Vaccination Market Share by Country (2017-2028)
    Figure 21. Germany Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Influenza Vaccination Market Share by Region (2017-2028)
    Figure 29. China Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Influenza Vaccination Market Share by Country (2017-2028)
    Figure 37. Mexico Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Influenza Vaccination Market Share by Country (2017-2028)
    Figure 41. Turkey Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 44. AstraZeneca (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 45. BioCryst Pharmaceuticals (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 46. Novartis (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 47. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 48. GlaxoSmithKline (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 49. Hualan Biological Engineering (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 50. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 51. F. Hoffmann-La Roche (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 52. Sanofi (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Frequently Asked Questions
Influenza Vaccination report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Influenza Vaccination report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Influenza Vaccination report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Greek Yoghurt

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More